Associated Papers
KIT gene mutations in gastrointestinal stromal tumor.
Kang W et al.
Frontiers in Bioscience (landmark Edition), 2015
Deep sequencing of KIT, MET, PIK3CA, and PTEN hotspots in papillary thyroid carcinomas with distant metastases.
Gandolfi G et al.
Endocrine-related Cancer, 2014
Gastrointestinal stromal tumors with KIT exon 9 mutations: Update on genotype-phenotype correlation and validation of a high-resolution melting assay for mutational testing.
Künstlinger H et al.
The American Journal of Surgical Pathology, 2013
Extracellular domain c-kit mutation with duplication of Ser501Ala502 found in gastrointestinal stromal tumors is more imatinib- and nilotinib-sensitive than that with duplication of Ala502Tyr503.
Liu NN et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology, 2013
Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours.
Lasota J et al.
Histopathology, 2008
Detection of a new mutation in KIT exon 9 in a gastrointestinal stromal tumor.
Hostein I et al.
International Journal of Cancer, 2006
[c-kit and PDGFRA mutations in 60 cases of gastrointestinal stromal tumors (GISTs)].
He HY et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences, 2005
Select a paper to view details